Physician profile
Dane Collins Mitchell
NPI 1578209078
$917.38
in general payments reported to CMS, 2019-2025
14 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $294 · 2023: $27.18 · 2024: $92.34 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.57 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $293.82 | 2022 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2025 | |
| Noven Pharmaceuticals, INC. | $92.34 | 2024 | Xelstrym |
| Ucb, INC. | $63.26 | 2025 | Bimzelx |
| Abbvie INC. | $61.89 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $57.40 | 2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $46.34 | 2025 | |
| Sun Pharmaceutical Industries INC. | $42.32 | 2025 | |
| Lilly USA, LLC | $37.35 | 2025 | Taltz, Ebglyss |
| Incyte Corporation | $28.81 | 2025 | Opzelura |
| Supernus Pharmaceuticals, INC. | $27.18 | 2023 | Qelbree |
| Genzyme Corporation | $25.19 | 2025 | |
| Janssen Biotech, INC. | $23.20 | 2025 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $18.29 | 2025 | Siliq, Cabtreo, Jublia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dane Mitchell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.